Cargando…
Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone
Recently we reported a cytoplasmic sodium overload to cause a severe osmotic oedema in Duchenne muscular dystrophy (DMD). Our results suggested that this dual overload of sodium ions and water precedes the dystrophic process and persists until fatty muscle degeneration is complete. The present paper...
Autores principales: | LEHMANN-HORN, FRANK, WEBER, MARC-ANDRÉ, NAGEL, ARMIN M., MEINCK, HANS-MICHAEL, BREITENBACH, SIMON, SCHARRER, JOHANNES, JURKAT-ROTT, KARIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SpA
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440802/ https://www.ncbi.nlm.nih.gov/pubmed/22655515 |
Ejemplares similares
-
(23)Na MRI and myometry to compare
eplerenone vs. glucocorticoid treatment
in Duchenne dystrophy
por: A. Glemser, Philip, et al.
Publicado: (2017) -
The role of fibrosis
in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012) -
Eplerenone repolarizes muscle membrane through Na,K-ATPase activation by Tyr10 dephosphorylation
por: Breitenbach, Simon, et al.
Publicado: (2016) -
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial
por: Raman, Subha V., et al.
Publicado: (2017) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)